DETIL Trademark

Trademark Overview

On Thursday, September 19, 2019, a trademark application was filed for DETIL with the United States Patent and Trademark Office. The USPTO has given the DETIL trademark a serial number of 88622887. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by Nurix Therapeutics, Inc.. The DETIL trademark is filed in the Pharmaceutical Products category with the following description:

Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
detil

General Information

Serial Number88622887
Word MarkDETIL
Filing DateThursday, September 19, 2019
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6918676
Registration DateTuesday, December 6, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2020

Trademark Statements

Goods and ServicesBiological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
Certificate of Correction for RegistrationThe drawing is corrected to appear as follows: DETIL

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2019
Primary Code005
First Use Anywhere DateThursday, March 17, 2022
First Use In Commerce DateThursday, March 17, 2022

Trademark Owner History

Party NameNurix Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameNurix Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158
Party NameNurix Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Trademark Events

Event DateEvent Description
Monday, September 23, 2019NEW APPLICATION ENTERED
Wednesday, September 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2019ASSIGNED TO EXAMINER
Friday, December 20, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, December 20, 2019EXAMINERS AMENDMENT E-MAILED
Friday, December 20, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 20, 2019EXAMINER'S AMENDMENT ENTERED
Saturday, December 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 26, 2019ASSIGNED TO LIE
Wednesday, January 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 18, 2020SOU TEAS EXTENSION RECEIVED
Friday, September 18, 2020SOU EXTENSION 1 FILED
Friday, September 18, 2020SOU EXTENSION 1 GRANTED
Tuesday, September 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 5, 2021SOU TEAS EXTENSION RECEIVED
Friday, March 5, 2021SOU EXTENSION 2 FILED
Friday, March 5, 2021SOU EXTENSION 2 GRANTED
Tuesday, March 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 22, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 22, 2021SOU EXTENSION 3 FILED
Wednesday, September 22, 2021SOU EXTENSION 3 GRANTED
Friday, September 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 24, 2022SOU EXTENSION 4 FILED
Thursday, February 24, 2022SOU EXTENSION 4 GRANTED
Saturday, February 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, September 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 12, 2022SOU EXTENSION 5 FILED
Monday, September 26, 2022SOU EXTENSION 5 GRANTED
Tuesday, September 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 26, 2022TEAS STATEMENT OF USE RECEIVED
Monday, September 26, 2022USE AMENDMENT FILED
Wednesday, September 28, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 2, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 3, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, December 28, 2022TEAS SECTION 7 REQUEST RECEIVED
Monday, July 10, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 13, 2023CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, August 15, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Monday, November 24, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 24, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

detil immune related disorders cancer treatment pharmaceutical preparations biological